DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Focus forming reduction assay are 42




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
References
DrugRepV_0028Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0029Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2)
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0030Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B (Victoria lineage)
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0031Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B (Yamagata lineage)
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0032Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Sydney/185/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0033Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Singapore/TT1275/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0034Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Sydney/158/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0035Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09/A/Victoria/2500/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0036Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H1N1)pdm09 /A/Malaysia/2/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0037Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Victoria/1031/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0038Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Victoria/1035/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0039Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Victoria/92/2012
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0040Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Malaysia/22/2013
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0041Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
A(H3N2) /A/Sydney/236/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0042Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/South Australia/2/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0043Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/Canberra/1/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0044Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/South Australia/5/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_0045Nitazoxanide
Antiparasitic products, Insectisides and Repellents
Diarrhea
Influenza virus
B/ B/Perth/136/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3317Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
B/Brisbane/46/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3318Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
B/Sydney/39/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3319Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/Perth/265/2009
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3320Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/Osaka/180/2009
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3321Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/New Caledonia/104/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_3322Tizoxanide
Antiparasitic products, Insectisides and Repellents
Cryptosporidiosis and Giardiasis
Influenza virus
A/Newcastle/22/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5457Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Sydney/185/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5458Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Singapore/TT1275/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5459Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Sydney/158/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5460Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/2500/2016
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5461Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Malaysia/2/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5462Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/1031/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5463Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/1035/2010
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5464Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Victoria/92/2012
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5465Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Malaysia/22/2013
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5466Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
A/Sydney/236/2014
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5467Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/South Australia/2/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5468Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/Canberra/1/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5469Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/South Australia/5/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_5470Tizoxanide
Antiparasitic products, Insectisides and Repellents
Crytosporidiosis and Giardiasis
Influenza virus
B/Perth/136/2015
Pathway
Focus forming reduction assay
Decrease (50 %)
Approved, Investigational, Vet approved
28986103
DrugRepV_6167Baicalin
Plant extract
Influenza
Dengue virus
NA
Pathway
Focus forming reduction assay
Decrease
Phase II
24965553
DrugRepV_6220Baicalein
Plant extract
Influenza
Dengue virus
New Guinea C
Pathway
Focus forming reduction assay
Decrease (50 %)
Phase II
23140177
DrugRepV_7344Baicalein
Plant extract
Influenza
Japanese encephalitis virus
HE861351
Pathway
Focus forming reduction assay
Decrease (50 %)
Phase II
23222683
DrugRepV_7345Quercetin
Antioxidant
NA
Japanese encephalitis virus
HE861351
Pathway
Focus forming reduction assay
Decrease (50 %)
Experimental, Investigational
23222683